| Net income (loss) | 10.69M |
| Loss from discontinued operations | |
| Income (loss) from continuing operations | |
| Depreciation and amortization | |
| Stock-based compensation expense | 1.03M |
| Deferred revenue recognized | |
| Deferred loan costs recognized | 1.81M |
| Write-off of debt issuance costs | |
| Gain on sale of assets | -33.63M |
| Provision for excess and obsolete inventory | 132K |
| Other noncash items | -178K |
| Contributions to pension plans | 0 |
| Accounts receivable | 3.64M |
| Inventory | -1.64M |
| Prepaid expenses and other assets | |
| Accounts payable | -1.83M |
| Accrued and other liabilities | 966K |
| Net cash provided by (used in) operating activities | |
| Capital expenditures, net | -1.4M |
| Proceeds from sale of assets | 50.41M |
| Changes in nonoperating assets and liabilities | |
| Net cash used in investing activities | |
| Repayment of former Revolving Credit Agreement | |
| Repayment of former Senior Notes | |
| Net proceeds from Credit Facility | |
| Payments for deferred loan costs | |
| Proceeds from the issuance of common stock | |
| Net cash used in financing activities | -14.8M |
| Net decrease in cash and cash equivalents | 19.75M |
| Cash and cash equivalents at beginning of period | 1.35M |
| Cash and cash equivalents at end of period | 21.1M |